Literature DB >> 24625931

Persistent arthralgia among Chikungunya patients and associated risk factors in Chennai, South India.

V Ramachandran1, P Kaur, K Kanagasabai, S Vadivoo, M V Murhekar.   

Abstract

CONTEXT: Chikungunya (CHIK) fever is viral disease characterized by joint pain for prolonged duration in various settings. However, there are no reports of long-term follow-up of the CHIK patients from India. AIMS: We conducted a cohort study to describe the clinical manifestations, incidence of persistent arthralgia, and the associated risk factors among patients with CHIK identified during an outbreak in a suburb of Chennai, India.
MATERIALS AND METHODS: We conducted a retrospective cum prospective cohort study in Gowripet, Avadi, Chennai. We included all adult CHIK case patients identified during the outbreak. We conducted a nested case-control study to identify the risk factors for persistent arthralgia defined as a CHIK case experiencing arthralgia for more than 15 days from the date of onset of illness. We included all 81 patients and 81 randomly selected controls.
RESULTS: All 403 case patients had joint pain. Approximately 40% suffered joint pain for up to 1 month and 7% had it beyond 1 year. The most commonly affected types of joints were knee (96%), wrist (80%), and ankle (77%) joints. Regarding the number of types of joints affected, 36% had six types of joints, 23% had five types of joints, and 14% had three types of joints affected. The overall incidence of persistent arthralgia was 80%. High-grade fever, involvement of four or more types of joints, and joint swelling were significantly associated with persistent arthralgia.
CONCLUSIONS: High prevalence of persistent arthralgia indicates the need for appropriate treatment strategies to reduce the severity and duration of joint pain.

Entities:  

Mesh:

Year:  2014        PMID: 24625931     DOI: 10.4103/0022-3859.128795

Source DB:  PubMed          Journal:  J Postgrad Med        ISSN: 0022-3859            Impact factor:   1.476


  8 in total

1.  Chikungunya outbreak in Atmakur village, Medak district, Telangana State, India.

Authors:  Chengappa K Uthappa; Ramesh R Allam; Deepak Gunti; Chava Nalini; Prasada R Udaragudi; Geetha P Tadi; Manoj V Murhekar
Journal:  Indian J Med Res       Date:  2015-12       Impact factor: 2.375

Review 2.  The Range of Neurological Complications in Chikungunya Fever.

Authors:  T Cerny; M Schwarz; U Schwarz; J Lemant; P Gérardin; E Keller
Journal:  Neurocrit Care       Date:  2017-12       Impact factor: 3.210

3.  Role of cytokines, chemokines, C3a, and mannose-binding lectin in the evolution of the chikungunya infection.

Authors:  Berta N Restrepo; Katerine Marín; Paola Romero; Margarita Arboleda; Ana L Muñoz; Irene Bosch; Heriberto Vásquez-Serna; Orlando A Torres
Journal:  Am J Clin Exp Immunol       Date:  2022-06-15

4.  Fever and Prominent Arthralgia in a Traveler who Returned from Amazonia: Differentiating between Dengue Fever and Chikungunya Fever.

Authors:  Burke A Cunha; Arthur Gran; Natalie C Klein
Journal:  Infect Chemother       Date:  2015-06

5.  The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015.

Authors:  Leora R Feldstein; Esther M Ellis; Ali Rowhani-Rahbar; M Elizabeth Halloran; Brett R Ellis
Journal:  Am J Trop Med Hyg       Date:  2016-07-11       Impact factor: 2.345

6.  Clinical Spectrum of Chikungunya in Pakistan.

Authors:  Syeda Naqvi; Shehroz Bashir; Chintan Rupareliya; Abdullah Shams; Pirthvi Raj Giyanwani; Zeeshan Ali; Faiza Qamar; Vijesh Kumar; Vikash Talib
Journal:  Cureus       Date:  2017-07-06

Review 7.  Recent progress on chikungunya virus research.

Authors:  Wenxi An; Ningning Ge; Yilin Cao; Jin Sun; Xia Jin
Journal:  Virol Sin       Date:  2017-11-28       Impact factor: 4.327

8.  Post-chikungunya arthritis: a longitudinal study in a tertiary care hospital in Bangladesh.

Authors:  Sigma Hossain; Minhaj Rahim Choudhury; Md Ariful Islam; Md Masudul Hassan; Surayea Yeasmin; Farzana Hossain; Mohammad Mostafa Zaman
Journal:  Trop Med Health       Date:  2022-03-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.